Anumana announced today that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with help from Boston Scientific. Cambridge, Massachusetts–based Anumana said medtech giant Boston Scientific joined as a new investor in its Series C round. The undisclosed funding accelerates the development of a multimodal generative AI platform and software as a […]
Anumana
Anumana wins FDA clearance for ECG-AI algorithm
Anumana announced that it received FDA 510(k) clearance for its AI-powered ECG-AI LEF medical device. Cambridge, Massachusetts–based Anumana, an Nference portfolio company, worked in collaboration with Mayo Clinic. They designed the breakthrough medical device to detect low ejection fraction (LEF) in patients at risk of heart failure. The company’s pulmonary hypertension (PH) early detection algorithm […]
Anumana wins FDA breakthrough nod for AI algorithm that detects pulmonary hypertension
Anumana announced today that it received FDA breakthrough device designation for its pulmonary hypertension (PH) early detection algorithm. Cambridge, Massachusetts-based Anumana, formed by Mayo Clinic and nference and launched in 2021, designed its AI-enhanced, electrocardiograph (ECG)-based PH early detection algorithm as a precise, non-invasive screening tool to provide earlier diagnosis for patients with PH that […]
Mayo Clinic helps launch two new companies for improved diagnostics
Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched. Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform (RDMP) is designed to connect data with new AI algorithms and augment human decision-making within existing clinical workflows, according to a news release. “The dramatically increased use […]
